Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | RIPK1 | Q13546 | 2/20 | 0.41 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.41 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6477904 | 0.82 | L3MBTL1 (0.43) | AOC3L3MBTL1HPGD | |
| SCHEMBL6872400 | 0.82 | L3MBTL1 (0.43) | AOC3L3MBTL1HPGD | |
| SCHEMBL7015545 | 0.82 | L3MBTL1 (0.43) | AOC3L3MBTL1HPGD | |
| SCHEMBL27544526 | 0.79 | CHRM1 (0.40) | LMNAAOC3CHRM2CHRM1CHRM3 | |
| SCHEMBL3822984 | 0.78 | CES2 (0.41) | CES2CES1RIPK1 | |
| SCHEMBL3822983 | 0.78 | CES2 (0.41) | CES2CES1RIPK1 | |
| SCHEMBL5861497 | 0.78 | LMNA (0.44) | LMNACES2CES1MAPK1RIPK1 | |
| SCHEMBL5861661 | 0.76 | LMNA (0.42) | LMNACES2CES1MAPK1RIPK1 | |
| SCHEMBL28364975 | 0.76 | AKR1B1 (0.37) | LMNAHSD17B10POLB | |
| SCHEMBL28369015 | 0.76 | AKR1B1 (0.37) | LMNAHSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| CN-115003343-B | Device and method for analytically and sensitively determining the release of active ingredients from a release system | 西姆莱斯股份公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-115103719-B | Encapsulated fragrance based on natural amino acids | 西姆莱斯股份公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-114746407-B | Novel aromatic monothiol ketals as fragrances | 西姆莱斯股份公司 | 2024-06-21 | — | — | CN | disclosed |
| CN-113766969-B | Method for preparing microcapsules | 西姆莱斯股份公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117986090-A | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-113840540-B | Perfume or flavour mixture | 西姆莱斯股份公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-114901745-B | Colored particles | 西姆莱斯股份公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-112469685-B | Novel fragrances with rose scent | 西姆莱斯股份公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-114746407-A | Novel aromatic monothiol ketals as odorants | 西姆莱斯股份公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-113840540-A | Spice or flavouring mixtures | 西姆莱斯股份公司 | 2021-12-24 | — | — | CN | disclosed |
| CN-113766969-A | Process for preparing microcapsules | 西姆莱斯股份公司 | 2021-12-07 | — | — | CN | disclosed |
| CN-112469685-A | Novel flavoring agent with rose smell | 西姆莱斯股份公司 | 2021-03-09 | — | — | CN | disclosed |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | disclosed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | disclosed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | disclosed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | ACKR3, KIT, C3AR1 | LMNA 981/4885CES2 1677/4885CES1 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.